87 related articles for article (PubMed ID: 26291959)
1. Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience.
Allewelt H; Martin PL; Szabolcs P; Chao N; Buckley R; Parikh S
Pediatr Blood Cancer; 2015 Dec; 62(12):2216-22. PubMed ID: 26291959
[TBL] [Abstract][Full Text] [Related]
2. Immune reconstitution and survival, following hematopoietic stem cell transplantation in Omani patients with inborn errors of immunity.
Al-Tamemi S; Al-Rawas A; Al-Khabori M; Al-Farsi K; Al-Huneini M; Abdalla A; Al-Kindi S; Dennison D
Clin Immunol; 2024 Jul; 264():110263. PubMed ID: 38795901
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Stem Cell Transplantation in Patients with Heterozygous STAT1 Gain-of-Function Mutation.
Kiykim A; Charbonnier LM; Akcay A; Karakoc-Aydiner E; Ozen A; Ozturk G; Chatila TA; Baris S
J Clin Immunol; 2019 Jan; 39(1):37-44. PubMed ID: 30543054
[TBL] [Abstract][Full Text] [Related]
4. [Follow-up analysis of sex hormone levels and prognosis in women after hematopoietic stem cell transplantation].
Xu QW; Du YY; Lyu KK; Xu MM; Gu CY; Kang HZ; Feng SL; Liu YJ; Wu DP; Han Y
Zhonghua Nei Ke Za Zhi; 2023 Nov; 62(11):1303-1310. PubMed ID: 37935496
[No Abstract] [Full Text] [Related]
5. Outcome of Second Allogeneic HSCT for Patients with Inborn Errors of Immunity: Retrospective Study of 20 Years' Experience.
Mehta P; Tsilifis C; Lum SH; Slatter MA; Hambleton S; Owens S; Williams E; Flood T; Gennery AR; Nademi Z
J Clin Immunol; 2023 Nov; 43(8):1812-1826. PubMed ID: 37452206
[TBL] [Abstract][Full Text] [Related]
6. Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency.
Freeman AF; Yazigi N; Shah NN; Kleiner DE; Parta M; Atkinson P; Heller T; Holland SM; Kaufman SS; Khan KM; Hickstein DD
Transplantation; 2019 Oct; 103(10):2144-2149. PubMed ID: 30720689
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.
de la Morena MT; Leonard D; Torgerson TR; Cabral-Marques O; Slatter M; Aghamohammadi A; Chandra S; Murguia-Favela L; Bonilla FA; Kanariou M; Damrongwatanasuk R; Kuo CY; Dvorak CC; Meyts I; Chen K; Kobrynski L; Kapoor N; Richter D; DiGiovanni D; Dhalla F; Farmaki E; Speckmann C; Español T; Shcherbina A; Hanson IC; Litzman J; Routes JM; Wong M; Fuleihan R; Seneviratne SL; Small TN; Janda A; Bezrodnik L; Seger R; Raccio AG; Edgar JD; Chou J; Abbott JK; van Montfrans J; González-Granado LI; Bunin N; Kutukculer N; Gray P; Seminario G; Pasic S; Aquino V; Wysocki C; Abolhassani H; Dorsey M; Cunningham-Rundles C; Knutsen AP; Sleasman J; Costa Carvalho BT; Condino-Neto A; Grunebaum E; Chapel H; Ochs HD; Filipovich A; Cowan M; Gennery A; Cant A; Notarangelo LD; Roifman CM
J Allergy Clin Immunol; 2017 Apr; 139(4):1282-1292. PubMed ID: 27697500
[TBL] [Abstract][Full Text] [Related]
8. Predictors of the development of surgical complications among hematopoietic stem cell transplantation recipients.
Anabtawi I; Abdelrahman F; Alomari A; Ba'ba' M; Al Masri M
World J Surg; 2012 May; 36(5):1003-1010. PubMed ID: 22374543
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Immunological Features, Genetic Variants, and Outcomes of Patients with CD40 Deficiency.
Banday AZ; Nisar R; Patra PK; Kaur A; Sadanand R; Chaudhry C; Bukhari STA; Banday SZ; Bhattarai D; Notarangelo LD
J Clin Immunol; 2023 Dec; 44(1):17. PubMed ID: 38129705
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell Transplantation in Children with very Early Onset Inflammatory Bowel Disease Secondary to Monogenic Disorders of immune-dysregulation.
Meena S; Varla H; Swaminathan VV; Chandar R; Jayakumar I; Ramakrishnan B; Uppuluri R; Raj R
Indian J Hematol Blood Transfus; 2023 Apr; 39(2):183-190. PubMed ID: 37006985
[No Abstract] [Full Text] [Related]
11. Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect.
Ott de Bruin LM; Pico-Knijnenburg I; van Ostaijen-Ten Dam MM; Weitering TJ; Berghuis D; Bredius RGM; Lankester AC; van der Burg M
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958995
[TBL] [Abstract][Full Text] [Related]
12. HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh.
Chandrakasan S; Chandra S; Prince C; Kobrynski LJ; Lucas L; Patel K; Walter J; Buckley RH; Meisel R; Ghosh S; Parikh SH
Blood Adv; 2022 Jun; 6(12):3751-3755. PubMed ID: 35443026
[TBL] [Abstract][Full Text] [Related]
13. Food allergies can persist after myeloablative hematopoietic stem cell transplantation in dedicator of cytokinesis 8-deficient patients.
Happel CS; Stone KD; Freeman AF; Shah NN; Wang A; Lyons JJ; Guerrerio PA; Hickstein DD; Su HC
J Allergy Clin Immunol; 2016 Jun; 137(6):1895-1898.e5. PubMed ID: 26827248
[No Abstract] [Full Text] [Related]
14. "Uncovering" the recovery of natural killer cells after reduced-intensity conditioning transplantation.
Bachanova V
Biol Blood Marrow Transplant; 2015 Mar; 21(3):383-4. PubMed ID: 25615609
[No Abstract] [Full Text] [Related]
15. Association between neutropenia and IgG antineutrophil antibodies in a case of
Assing K; Nielsen KR; Tenstad HB; Jakobsen MA; Nielsen C; Grosen D; Hartling UB
Clin Case Rep; 2020 Feb; 8(2):313-316. PubMed ID: 32128179
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with LPS-responsive beige-like anchor protein deficiency after reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: report of two cases.
Jafari L; Mohseni R; Barhoom D; Abou Fakher FH; Behfar M; Hamidieh AA
Hematol Transfus Cell Ther; 2022 May; ():. PubMed ID: 35643917
[No Abstract] [Full Text] [Related]
17. Successful allogeneic stem cell transplantation with a reduced-intensity conditioning in a case of leukocyte adhesion deficiency type III.
Barhoom D; Behfar M; Mohseni R; Hamidieh AA
Hematol Transfus Cell Ther; 2024; 46(3):300-302. PubMed ID: 35256330
[No Abstract] [Full Text] [Related]
18. Successful cord blood transplantation using reduced intensity conditioning in a 5-month-old patient with IL-10RA deficiency.
Isobe K; Saida S; Honda Y; Nihira H; Hiejima E; Izawa K; Kubota H; Kato I; Umeda K; Hiramatsu H; Yasumi T; Takita J
Pediatr Blood Cancer; 2024 May; ():e31056. PubMed ID: 38721857
[No Abstract] [Full Text] [Related]
19. Hyper IgM Syndrome: a Report from the USIDNET Registry.
Leven EA; Maffucci P; Ochs HD; Scholl PR; Buckley RH; Fuleihan RL; Geha RS; Cunningham CK; Bonilla FA; Conley ME; Ferdman RM; Hernandez-Trujillo V; Puck JM; Sullivan K; Secord EA; Ramesh M; Cunningham-Rundles C
J Clin Immunol; 2016 Jul; 36(5):490-501. PubMed ID: 27189378
[TBL] [Abstract][Full Text] [Related]
20. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.
Hubbard N; Hagin D; Sommer K; Song Y; Khan I; Clough C; Ochs HD; Rawlings DJ; Scharenberg AM; Torgerson TR
Blood; 2016 May; 127(21):2513-22. PubMed ID: 26903548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
